Aminolab
Seoul
About Aminolab
Aminolab specializes in the development of blood resource recycling technology, aimed at addressing concerns associated with the environmental impact of waste blood treatment. Aminolab identifies the environmental burden of waste blood processing worldwide and prepares for improvement. Since 2013, the company has developed amino acid extraction technology through hydrolysis of slaughter blood using natural enzymes, and completed the construction of a factory for mass production in April 2022.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $8.5M
- Last round: Series Unknown (Jan 2023)
- Website: aminolab.co.kr
- Phone: +82 44-903-4470
Industries & Categories
Cosmetics, Renewable Energy, Waste Management
Social Profiles
Canonical: https://fsome.com/organization/aminolab-11003 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.